The Injection-Risk Literature Almost Nobody Reads

Debates about peptides usually centre on mechanism and efficacy. The published harm literature is dominated by something more mundane: infection from non-sterile technique and unverified product.

Case series and public-health reports describe skin and soft-tissue infection, abscess formation, and in a minority of cases bacteraemia and endocarditis linked to non-clinical injecting.

Why product identity matters here

Sterility and identity are separate questions. A vial can contain the labelled compound and still be contaminated; it can be sterile and still not contain what the label claims.

Certificates of analysis address identity and purity of a tested batch. They are not a sterility guarantee for the vial in front of you, and reading them as one is a common error.

Endotoxin is not the same as bacteria

Sterilisation can kill organisms while leaving bacterial endotoxin behind, which is why pharmaceutical manufacture tests for endotoxin separately. Research-grade material frequently has no endotoxin documentation at all.

This is a documented reason why material sold for laboratory use is labelled as unsuitable for human or veterinary use.

What this means for readers

Nothing on this site is a protocol for self-administration. We describe this literature because it is the risk with the strongest evidence base, and it is systematically underrepresented in enthusiast discussion.

Anyone considering any injectable therapy should be doing so under qualified medical supervision, with a pharmaceutical product.